# Dianthus Therapeutics, Inc.: Form 8-K, filed Jan 24, 2019

- Company: [Dianthus Therapeutics, Inc.](/companies/dnth.md) (CIK 1690585)
- Form: 8-K
- Filed: 2019-01-24
- Accepted by EDGAR: Jan 24, 2019, 16:15 ET
- Period: 2019-01-17
- Accession: 0001193125-19-015933
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1690585/000119312519015933/d696332d8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1690585/000119312519015933/

## Items reported

- Item 8.01: Other events

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1690585/000119312519015933/d696332d8k.htm

Filed Jan 24, 2019.
Source: SEC EDGAR, the filing index for accession 0001193125-19-015933. Last ingested by Listed: Nov 13, 2026, 16:49 ET. No prices; not investment advice.